Autophagy: A targetable linchpin of cancer cell metabolism

Trends in Endocrinology and Metabolism

Volumn 24, Issue 4, 2013, Pages 209-217

  Leone, Robert D ^a   Amaravadi, Ravi K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUTAMINE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE; UNC 51 LIKE KINASE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CELL AGING; CELL DEATH; CELL DIVISION; CELL METABOLISM; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; ENZYME INDUCTION; LYSOSOME MEMBRANE; MALIGNANT TRANSFORMATION; METABOLIC REGULATION; METABOLIC STRESS; MITOCHONDRION; MITOPHAGY; MITOSIS SPINDLE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SUGAR TRANSPORT; TUMOR MICROENVIRONMENT;

ANIMALS; AUTOPHAGY; HUMANS; NEOPLASMS;

EID: 84877905545     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.01.008     Document Type: Review

References (88)

1. Warburg O. über den Stoffwechsel der Carcinomzelle. Klin. Wochenschr. 1925, 4:534-536. (in German).
2. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
3. DeBerardinis R.J., et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7:11-20.
4. Mathew R., White E. Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:389-396.
5. Cheong H., et al. Therapeutic targets in cancer cell metabolism and autophagy. Nat. Biotechnol. 2012, 30:671-678.
6. Mizushima N., et al. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
7. Mathew R., White E. Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr. Opin. Genet. Dev. 2011, 21:113-119.
8. Kanzawa T., et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004, 11:448-457.
9. Wu W.K., et al. Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy. Drug Resist. Updat. 2010, 13:87-92.
10. Amaravadi R.K., et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
11. Lum J.J., et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120:237-248.
12. Ravikumar B., et al. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 2006, 15:1209-1216.
13. Mathew R., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
14. Pandey U.B., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447:859-863.
15. Manjithaya R., et al. Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. J. Cell Biol. 2010, 188:537-546.
16. Kuo T.C., et al. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat. Cell Biol. 2011, 13:1214-1223.
17. Qu X., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112:1809-1820.
18. Lazova R., et al. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin. Cancer Res. 2012, 18:370-379.
19. Ma X.H., et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin. Cancer Res. 2011, 17:3478-3489.
20. Edinger A.L., Thompson C.B. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 2002, 13:2276-2288.
21. Buzzai M., et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 2005, 24:4165-4173.
22. Elstrom R.L., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64:3892-3899.
23. Hatzivassiliou G., et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8:311-321.
24. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 2009, 10:307-318.
25. Bernardi R., et al. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 2006, 442:779-785.
26. Zhong H., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000, 60:1541-1545.
27. Kim J.W., et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
28. Kim J.W., et al. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 2007, 27:7381-7393.
29. Shim H., et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6658-6663.
30. Iyer N.V., et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998, 12:149-162.
31. Wise D.R., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18782-18787.
32. Guo J.Y., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25:460-470.
33. Deberardinis R.J., et al. Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J. Biol. Chem. 2006, 281:37372-37380.
34. Elgendy M., et al. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell 2011, 42:23-35.
35. Wu S.Y., et al. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation. Neoplasia 2011, 13:1171-1182.
36. Portais J.C., et al. Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR. Biochimie 1996, 78:155-164.
37. Yuneva M., et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 2007, 178:93-105.
38. Mullen A.R., et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2011, 481:385-388.
39. Wise D.R., et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19611-19616.
40. Klimova T., Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008, 15:660-666.
41. Eng C.H., et al. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci. Signal. 2010, 3:ra31.
42. Zhang H., et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008, 283:10892-10903.
43. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279-296.
44. Noman M.Z., et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res. 2011, 71:5976-5986.
45. Bellot G., et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 2009, 29:2570-2581.
46. Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 2011, 13:1016-1023.
47. Green D.R., et al. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011, 333:1109-1112.
48. Geisler S., et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12:119-131.
49. Amaravadi R.K., et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 2007, 117:326-336.
50. Young A.R., et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 2009, 23:798-803.
51. Jung C.H., et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 2009, 20:1992-2003.
52. Long X., et al. Rheb binds and regulates the mTOR kinase. Curr. Biol. 2005, 15:702-713.
53. Kim D.H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
54. Sancak Y., et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
55. 2+/CaM signaling to hVps34. Cell Metab. 2008, 7:456-465.
56. Findlay G.M., et al. A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem. J. 2007, 403:13-20.
57. Ganley I.G., et al. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J. Biol. Chem. 2009, 284:12297-12305.
58. Hart L.S., et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J. Clin. Invest. 2012, 122:4621-4634.
59. Spowart J.E., et al. The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J. Pathol. 2012, 228:437-447.
60. Liang J., et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 2007, 9:218-224.
61. Egan D.F., et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331:456-461.
62. Alexander A., Walker C.L. Differential localization of ATM is correlated with activation of distinct downstream signaling pathways. Cell Cycle 2010, 9:3685-3686.
63. Feng Z., et al. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8204-8209.
64. Feng Z., Levine A.J. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol. 2010, 20:427-434.
65. Singh K., et al. Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy 2012, 8:236-251.
66. Bernales S., et al. ER-phagy: selective autophagy of the endoplasmic reticulum. Autophagy 2007, 3:285-287.
67. Malhotra J.D., Kaufman R.J. The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 2007, 18:716-731.
68. Appenzeller-Herzog C., Hall M.N. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 2012, 22:274-282.
69. Semenza G.L. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim. Biophys. Acta 2011, 1813:1263-1268.
70. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330:1344-1348.
71. Wu H., et al. Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death. J. Pathol. 2012, 227:189-199.
72. Xi H., et al. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother. Pharmacol. 2011, 67:899-910.
73. Lin T.C., et al. Autophagy: resetting glutamine-dependent metabolism and oxygen consumption. Autophagy 2012, 8:1477-1493.
74. Rong Y., et al. Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7826-7831.
75. Le Guezennec X., et al. Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metab. 2012, 16:68-80.
76. Martinez-Outschoorn U.E., et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int. J. Biochem. Cell Biol. 2011, 43:1045-1051.
77. Sotgia F., et al. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the 'reverse Warburg effect' in positive lymph node tissue. Cell Cycle 2012, 11:1445-1454.
78. Sotgia F., et al. Mitochondria 'fuel' breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. Cell Cycle 2012, 11:4390-4401.
79. Sotelo J., et al. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2006, 144:337-343.
80. McAfee Q., et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:8253-8258.
81. Gorski S.M., et al. Targeting autophagy: the Achilles' heel of cancer. Autophagy 2012, 8:1279-1280.
82. Frezza C., et al. Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival. PLoS ONE 2011, 6:e24411.
83. Frankel L.B., Lund A.H. MicroRNA regulation of autophagy. Carcinogenesis 2012, 33:2018-2025.
84. Yue Z., et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15077-15082.
85. Liang X.H., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
86. Komatsu M., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131:1149-1163.
87. Komatsu M., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 2005, 169:425-434.
88. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.